| Politician | Action | Description | Traded |
|---|---|---|---|
| Buy | Guardant Health, Inc. | Sep 28, 2026 | |
| Buy | Guardant Health Inc | Nov 21, 2025 | |
| Buy | GUARDANT HEALTH INC CMN | Apr 13, 2022 | |
| Sell | GUARDANT HEALTH INC | Jan 31, 2022 | |
| Sell | guardant Health, Inc. | Dec 22, 2021 | |
| Executed Option | GUARDANT HEALTH INC EXECUTED | Dec 28, 2020 | |
| Buy | guardant Health, Inc. | Nov 2, 2020 | |
| Buy | Guardant Health, Inc. | Oct 22, 2020 | |
| Buy | Guardant Health, Inc. | Oct 5, 2020 |
This page tracks congressional stock trading activity in Guardant Health, Inc. (GH) in the Healthcare sector. Disclosed Capitol has indexed 9 disclosed congressional trades involving GH. Every trade is sourced from official STOCK Act financial disclosure filings — the same primary records the Senate and House are required to publish. The full trade list with politician names, transaction types, amount ranges, and disclosure dates is below, alongside cross-references to any related lobbying activity, federal contracts, and committee assignments.
As of October 2026 — Disclosed Capitol has tracked 9 disclosed congressional trades in Guardant Health, Inc. (GH) — 6:3 buy-heavy ratio — led by Donald Sternoff Beyer (D).
| Date | Politician | Party | Action | Amount |
|---|---|---|---|---|
| Sep 28, 2026 | Jonathan Jackson | D | Buy | $15,001 - $50,000 |
| Nov 21, 2025 | Sheldon Whitehouse | D | Buy | $1,001 - $15,000 |
| Apr 13, 2022 | Ro Khanna | D | Buy | $1,001 - $15,000 |
| Jan 31, 2022 | Ro Khanna | D | Sell | $1,001 - $15,000 |
| Dec 22, 2021 | Donald Sternoff Beyer | D | Sell | $1,001 - $15,000 |
| Dec 28, 2020 | Phil Roe | R | Sell | $1,001 - $15,000 |
| Nov 2, 2020 | Donald Sternoff Beyer | D | Buy | $1,001 - $15,000 |
| Oct 22, 2020 | Donald Sternoff Beyer | D | Buy | $1,001 - $15,000 |
| Oct 5, 2020 | Donald Sternoff Beyer | D | Buy | $1,001 - $15,000 |
Across the 9 disclosed congressional trades in Guardant Health, Inc. (GH), members of Congress have reported 6 buys and 3 sells. The average 30-day alpha vs. the S&P 500 is -7.05%.
For fiscal year 2025, Guardant Health, Inc. reported revenue of $982.0M and net income of -$416.3M, per SEC filings.
Most recent reported quarter: Q2 FY2026 — revenue $335.0M, net income -$120.1M.
Figures come from SEC financial statement filings. The full annual and quarterly statement history is in the Financials tab above.